
Synergistic combination that stimulates natural growth hormone release without raising cortisol or prolactin — the "cleanest" secretagogue available.
Ranges cited in research literature. Not a usage recommendation. For research use only.
This vial combines two peptides that act on growth-hormone secretion through different routes: CJC-1295 without DAC (Mod GRF 1-29), a 29-amino-acid analog of growth-hormone-releasing hormone, and ipamorelin, a synthetic pentapeptide that mimics ghrelin. They come co-lyophilized in equal parts (5 mg + 5 mg, or 10 mg + 10 mg in the 20 mg presentation). It is the most widely used GHRH + secretagogue pairing in the research market.
The rationale for the combination is physiological and documented for both classes: GHRH acts on its pituitary receptor and increases the amount of GH released in each pulse, while ghrelin-receptor (GHSR-1a) agonists amplify that pulse, inhibit somatostatin and also act in the hypothalamus. In humans, co-administration of GHRH and a GHRP produces a GH release greater than the sum of each alone, a synergy described since the 1990s with GHRP-6 and GHRP-2.
What does not exist is a clinical trial of this specific mixture: ipamorelin's evidence is preclinical and from early human studies, and Mod GRF 1-29's is mostly pharmacokinetic. Both have short half-lives (ipamorelin about 2 hours; Mod GRF around 30 minutes), so the GH pattern they generate is pulsatile, not sustained. Like anything that raises GH and IGF-1, it carries the usual theoretical caution in tumor contexts. Renova distributes it for research only.
| Composition | Mod GRF (1-29) + Ipamorelin co-lyophilized 1:1 · 10 mg (5+5) or 20 mg (10+10) |
| Mod GRF (1-29) | GHRH(1-29) with D-Ala2, Gln8, Ala15, Leu27 · 3368 g/mol · half-life ≈ 30 min |
| Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2 · 711.9 g/mol · CAS 170851-70-4 · half-life ≈ 2 h |
| Receptors | GHRH-R (pituitary) + GHSR-1a (ghrelin receptor) |
| Mechanism of the pair | GHRH raises GH pulse amplitude; the GHSR agonist amplifies it and inhibits somatostatin |
| Evidence | GHRH + GHRP synergy documented in humans for the classes; no trial of this combination |
| Ipamorelin profile | No relevant rise in cortisol, prolactin or appetite in studies |
| Regulatory status | Neither component approved; GHRH and secretagogues on the WADA list (S2) |
Because they act on different receptors of the same somatotroph cell and potentiate each other: GHRH increases how much GH leaves in each pulse, and the ghrelin agonist amplifies the pulse and inhibits somatostatin, the natural brake. In humans GH release with both classes together exceeds the sum of each alone.
This vial carries the no-DAC version (Mod GRF 1-29), short-acting (about 30 minutes), which generates GH pulses resembling physiological ones. The DAC version binds albumin and lasts days, raising GH continuously; it is not the one in this combination.
Its selectivity. In Novo Nordisk's original studies (1998), ipamorelin released GH without raising ACTH, cortisol or prolactin, unlike GHRP-6 and GHRP-2, and it does not stimulate appetite the way GHRP-6 does. That is why it is the secretagogue that usually accompanies GHRH in research.
Not of the combination. There are human studies of each class (GHRH and GHRP) and of their synergy, pharmacokinetic studies of Mod GRF 1-29, and preclinical and early-phase data on ipamorelin. The specific mixture is a research-market practice.
Related reading: CJC-1295 + Ipamorelin: The Most-Studied GH Stack · Peptide Stacking: Synergy, Sequencing, and Combinations
Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.
Zones: Santo Domingo · Santiago · Punta Cana · La Romana
Delivery in Santo Domingo in about 2–4 business hours and nationwide in about 6–12 business hours by courier with tracking (RD$400). Reconstituted compounds travel cold-chain (2–8°C) in thermal packaging.
We publish Janoshik Analytical certificates of analysis (HPLC + mass spectrometry) at renovapeptides.do/coa/ — review the library before ordering.
Orders are confirmed over WhatsApp. Payment: Payment Link (PayPal — card, Apple Pay or Venmo), bank transfer, or pay on delivery in Santo Domingo (cash or transfer on receipt).
There is no minimum order. Automatic cart discounts: same-product volume (3+ units 15%, 5+ 25%, 10+ 40%) and Mix & Match across different products (3+ items 10%, 5+ 15%, 7+ 20%; not applicable to Retatrutide or Tirzepatide). The better of the two applies per product; bacteriostatic water is excluded and promo codes can't be combined.
📖 Full guide: CJC-1295 + Ipamorelin: The Most-Studied GH Stack
Your cart is empty